Excellence in Hemoglobinopathies Research Award Program
Page 2

It is the hope of the NHLBI that the proposals will pave the way to several interdisciplinary approaches to translational research in the hemoglobinopathies, which entails a higher likelihood of high-impact research eventually becoming applied clinical research studies.

The end goal of the studies that will be proposed under this project is centered on the discovery of small molecules, biologics, and biomarkers that can all be utilized in the process of diagnosing, treating, and managing sickle cell disease or the thalassemias.

The NHLBI is set to administer 7 to 10 grant awards with an overall budget of $72.85, with a total cost of $14 million for the year 2013 alone.

The organizations and institutions that will be deemed eligible to submit an application under the Excellence in Hemoglobinopathies Research Award Program are the following:

a) Higher Education Institutions such as Public/State Controlled Institutions of Higher Education and Private Institutions of Higher Education

b) Nonprofits Other Than Institutions of Higher Education

c) For-Profit Organizations such as Small Businesses and other organizations other than Small Businesses

d) State Governments, County Governments, City or Township Governments and Special District Governments

e) Independent School Districts, Public Housing Authorities/Indian Housing Authorities, Native American Tribal Organizations (other than Federally recognized tribal governments), Faith-based or Community-based Organizations, and Regional Organizations.

Excellence in Hemoglobinopathies Research Award Program
  Back to Page 1

About The Author Michael Saunders is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. He also maintains Websites providing resources on artist grants and children grants.

Additional Resources

category - Health Grants

Small Business Innovation Research Phase IIB Bridge Awards
In line with this mission, the NIH has recently constituted the Small Business Innovation Research Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization Program.

---

Basic Research on HIV Persistence Program
In keeping with this mission, the National Institutes of Health has recently constituted the establishment of the Basic Research on HIV Persistence Program in an attempt to increase our understanding of the persistence of HIV-1 infections in patients under highly active anti-retroviral therapy (HAART).

---

Genomic Advances to Wound Repair
The National Institutes of Health has coordinated with the National Institute of Nursing Research (NINR) to establish a program called Genomic Advances to Wound Repair in an effort to jump-start research studies that have the potential to deepen the understanding of genomic mechanism associated with the repair and development of wounds that are chronic in nature, which implies that these wounds have failed to enter into a reparative process after three months.

---

Cancer Education Grants Program
The Cancer Education Grants Program has been existent since the year 1994 and has long been providing support to innovative cancer education grants program that aim to translate the knowledge obtain from the research studies into actual public health applications.

---